Sempra Energy (SRE) Pops 2.69% for January 22

Equities Staff |

One of the S&P 500’s big winners for Friday January 22 was Sempra Energy (SRE) as the company’s stock climbed 2.69% to $93.49 on volume of 921,735 shares.

The stock opened at $91.68 and saw an intraday low of $91.39 and an intraday high of $93.85. All told, the day saw a per-share gain of $2.445. The stock’s average daily volume of 1.39 million and 248.21 million shares outstanding. Sempra Energy now has a 50-day SMA is $95.18 and 200-day SMA is $98.83, and it has a 52-week high of $116.21 and a 52-week low of $86.72.

Sempra Energy is an energy services holding company, which provides electric, natural gas and other energy products and services to its customers.

Based out of San Diego, CA, Sempra Energy has 17,046 employees and, after today’s trading, reached a market cap of $23.2 billion. The stock’s P/E Ratio is 17.9. Its P/S ratio is 3, P/B ratio is 2, and P/FCF ratio is -21.1.

For a complete fundamental analysis analysis of Sempra Energy, check out’s Stock Valuation Analysis report for SRE. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Cavitation Techs Inc

Cavitation Technologies Inc engineers and designs Nano technology based systems that have potential applications in industrial liquid processing.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…